Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity()()

Detalles Bibliográficos
Autores principales: Moin, Abu Saleh Md, Sathyapalan, Thozhukat, Atkin, Stephen L., Butler, Alexandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
COVID-19 in Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510340/
https://www.ncbi.nlm.nih.gov/pubmed/32949593
http://dx.doi.org/10.1016/j.metabol.2020.154374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510340/
https://www.ncbi.nlm.nih.gov/pubmed/32949593
http://dx.doi.org/10.1016/j.metabol.2020.154374

Ejemplares similares